Amgen Inc.
AMGNNASDAQHealthcare● Active
$349.58
+$3.98(+1.15%)
Market Cap$188.7B
P/E Ratio—
52W High$391.29
52W Low$267.83
Amgen Inc. (AMGN) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AMGN · as of 2026-06-08
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $7.71B | $4.09B | $6.72B | $6.55B | $5.89B |
| Depreciation & Amort. | $5.17B | $5.59B | $4.07B | $3.42B | $3.40B |
| Stock-Based Comp. | $0.00B | $0.53B | $0.43B | $0.40B | $0.34B |
| Change in Working Capital | ($1.98B) | $2.37B | ($0.48B) | ($0.73B) | ($1.19B) |
| Net Cash from Operations | $9.96B | $11.49B | $8.47B | $9.72B | $9.26B |
| Investing Activities | |||||
| Capital Expenditure | ($1.86B) | ($1.10B) | ($1.11B) | ($0.94B) | ($0.88B) |
| Purchases of Investments | $0.00B | $0.00B | ($0.00B) | ($2.59B) | ($8.90B) |
| Sales of Investments | $0.00B | $0.00B | $1.67B | $1.22B | $13.23B |
| Net Cash from Investing | ($1.94B) | ($1.05B) | ($26.20B) | ($6.04B) | $0.73B |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | ($0.20B) | $0.00B | ($6.36B) | ($4.97B) |
| Dividends Paid | ($5.12B) | ($4.83B) | ($4.56B) | ($4.20B) | ($4.01B) |
| Debt Issued / Repaid | ($5.68B) | ($4.26B) | $25.68B | $6.62B | $0.80B |
| Net Cash from Financing | ($10.86B) | ($9.41B) | $21.05B | ($4.04B) | ($8.27B) |
| Free Cash Flow | |||||
| Free Cash Flow | $8.10B | $10.39B | $7.36B | $8.79B | $8.38B |
| FCF Margin %(computed) | 22.05% | 31.10% | 26.11% | 33.37% | 32.26% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Amgen Inc. data
About Amgen Inc. (AMGN) Cash Flow Statement
Amgen Inc. generated operating cash flow of $9.96B and free cash flow of $8.10B for 2025 — a FCF margin of 22.05%. Capital expenditure was ($1.86B).
Frequently asked questions
AMGN · 4 questionsAmgen Inc. generated free cash flow of $8.10B for 2025, down 22.1% year-over-year.
AMGN free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08